News

The STAR collaboration at BNL has narrowed the search for a long-sought-after “critical point” in the still largely ...
Bargersville’s recent growth spurt has been rapid, but town officials say they want to be methodical in their planning for ...
Monarch Research has teamed up with Linn County Master Gardeners to launch the Native Oasis Pollinator Patch Program, an ...
Discover how CCUS-EOR technology can enhance oil recovery while reducing carbon emissions. A new study in Engineering ...
An analysis of four different topologies to meet ATE SMU requirements with a final, the two-stage approach as the most ...
Representatives for the proposal appeared before the Holland Planning Commission on June 10.
The phase 3 IRAKLIA trial assesses subcutaneous isatuximab via on-body injector vs intravenous (IV) administration, in combination with pomalidomide and dexamethasone, in relapsed/refractory ...
Rhythm Pharmaceuticals announced three late-breaking abstracts accepted for presentation at ENDO 2025, highlighting new research on acquired hypothalamic obesity treatments.
Researchers developed a copper-based growth process that produces large-area trilayer graphene films with uniform thickness ...
A phase III double blinded study of early intervention after radical prostatectomy with androgen deprivation therapy with darolutamide versus placebo in men at highest risk of prostate cancer ...
Learn about the Sikkim TET Syllabus 2025, including topic-wise syllabus, weightage, preparation tips, and more on this page.
Pfizer Inc. is embarking on a Phase 1 clinical study titled ‘A PHASE 1, RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, SINGLE DOSE-ESCALATION AND MULTIPLE DOSE STUDY ...